414 related articles for article (PubMed ID: 17584075)
1. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
[TBL] [Abstract][Full Text] [Related]
2. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
3. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
[TBL] [Abstract][Full Text] [Related]
4. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes.
McMurry J; Sbai H; Gennaro ML; Carter EJ; Martin W; De Groot AS
Tuberculosis (Edinb); 2005; 85(1-2):95-105. PubMed ID: 15687033
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
6.
Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
[TBL] [Abstract][Full Text] [Related]
7. New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope.
Shi C; Zhang H; Zhang T; Wang X; Bai B; Zhao Y; Zhang C; Xu Z
Scand J Immunol; 2009 Nov; 70(5):465-74. PubMed ID: 19874551
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.
Nayak K; Jing L; Russell RM; Davies DH; Hermanson G; Molina DM; Liang X; Sherman DR; Kwok WW; Yang J; Kenneth J; Ahamed SF; Chandele A; Murali-Krishna K; Koelle DM
Tuberculosis (Edinb); 2015 May; 95(3):275-87. PubMed ID: 25857935
[TBL] [Abstract][Full Text] [Related]
9. Developing an epitope-driven tuberculosis (TB) vaccine.
De Groot AS; McMurry J; Marcon L; Franco J; Rivera D; Kutzler M; Weiner D; Martin B
Vaccine; 2005 Mar; 23(17-18):2121-31. PubMed ID: 15755582
[TBL] [Abstract][Full Text] [Related]
10. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in
Ramaiah A; Nayak S; Rakshit S; Manson AL; Abeel T; Shanmugam S; Sahoo PN; John AJUK; Sundaramurthi JC; Narayanan S; D'Souza G; von Hoegen P; Ottenhoff THM; Swaminathan S; Earl AM; Vyakarnam A
Front Immunol; 2019; 10():195. PubMed ID: 30814998
[TBL] [Abstract][Full Text] [Related]
12. Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis.
Wang X; Chen S; Xu Y; Zheng H; Xiao T; Li Y; Chen X; Huang M; Zhang H; Fang X; Jiang Y; Li M; Liu H; Wan K
Emerg Microbes Infect; 2017 Jun; 6(6):e48. PubMed ID: 28588287
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
[TBL] [Abstract][Full Text] [Related]
15. [Identification and evaluation of T cell epitopes of Rv0585c from
Wang XX; Chen X; Li YQ; Xiao TY; Jiang Y; Li MC; Liu HC; Wan KL
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):665-669. PubMed ID: 28651408
[No Abstract] [Full Text] [Related]
16. Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.
Commandeur S; Coppola M; Dijkman K; Friggen AH; van Meijgaarden KE; van den Eeden SJ; Wilson L; van der Ploeg-van Schip JJ; Franken KL; Geluk A; Ottenhoff TH
PLoS One; 2014; 9(6):e99203. PubMed ID: 24905579
[TBL] [Abstract][Full Text] [Related]
17. In silico predicted mycobacterial epitope elicits in vitro T-cell responses.
Khan MK; Zaman S; Chakraborty S; Chakravorty R; Alam MM; Bhuiyan TR; Rahman MJ; Fernández C; Qadri F; Seraj ZI
Mol Immunol; 2014 Sep; 61(1):16-22. PubMed ID: 24853589
[TBL] [Abstract][Full Text] [Related]
18. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis.
Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J
Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013
[TBL] [Abstract][Full Text] [Related]
20. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]